Rajeshwer Singh Sankhala

1 Patent

• US118847182024

  Potent Zika Virus-specific and Cross-neutralizing Monoclonal Antibodies to Zika and Dengue Viruses Following ZIKV Infection or Vaccination

  The Government Of The United States As Represented By The Secretary Of The Army

  0 cites